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Last June the National Institute ofMental Health adopted new pri-
orities to address the AIDS epidemic
among people with severe mental ill-
ness. Besides prevention and treat-
ment, the priorities emphasize the
need for a fuller understanding of the
extent and social organization of sexu-
al and drug use behavior, the nation-
wide prevalence of HIV, and the na-
ture of causality between mental ill-
ness and HIV infection (1).
Eleven studies of 2,873 predomi-
nantly hospital-based psychiatric pa-
tients in New York City, Baltimore,
and Columbia, South Carolina, indi-
cate the average HIV infection rate
among adults with severe mental ill-
ness is 7.8 percent (2), nearly 20 times
the rate of .4 percent estimated for
the general population (3). Across
studies, psychiatric patients with
identified comorbid alcohol or other
drug use disorders have a significant-
ly higher rate of infection than those
without (χ2=47.56, df=9, p<.001) (see
Figure 1). Among patients treated on
dual diagnosis units, HIV seropreva-
lence is significantly related to type of
substance used (χ2=8.82, df=2, p<
.03) (see Figure 2).
Drug injection confers the highest
risk, but even use of noninjected
drugs or alcohol alone resulted in
rates of infection substantially higher
than the average rate. Patients with
alcohol or other drug use disorders
may be members of social networks
where sex and drugs combine to cre-
ate vulnerability to sexually transmit-
ted HIV infection.
Mental health care providers are of-
ten in the best position to assess pa-
tients’ sexual and drug use behaviors.
Only by asking can providers learn their
patients’ HIV-related risks and service
needs and appropriately address them
to reduce the human and economic
costs of the AIDS epidemic. '
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Datapoints
Figure 1
HIV infection rate (in percentages) among 2,873 psychiatric
patients, by treatment setting
Figure 2
HIV infection rate (in percentages) among 174 patients on
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